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Intrathoracic peripheral nerve sheath tumors in patients with
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Intrathoracic neurogenic tumors comprise 15% to 25% of allprimary mediastinal tumors in adults, and 95% originatewithin the posterior mediastinum.1 In most, these are benignslow-growing schwannomas and neurofibromas of periph-
eral nerve origin. However, patients with neurofibromatosis type 1
(NF1) are particularly at risk for malignant transformation of these
tumors and have a poor long-term prognosis.2
Clinical Summaries
We present 3 cases of intrathoracic peripheral nerve sheath tumors
in patients with NF1 disease.
PATIENT 1. A 55-year-old man presented with a recent onset of
dyspnea and a known posterior mediastinal mass diagnosed 20
years earlier. The mass had increased in size over the past 5 years.
Chest radiography revealed a smooth shadow adjacent to the right
upper thoracic spine, and computed tomographic (CT) scan con-
firmed a 4.3  3.4-cm low-attenuation mass occupying the right
posterior mediastinum. Intraoperative bronchoscopy results were
negative. He underwent a posterolateral thoracotomy with resec-
tion of a well-circumscribed 5  4  3-cm mass. The histopatho-
logic diagnosis was neurofibroma. His postoperative course was
uneventful, and he is doing well 15 months after resection.
PATIENT 2. A 35-year-old woman with prior resection of a
brachial plexus neurofibroma presented with recent onset of dys-
pnea. The chest radiograph showed a left perihilar mass. CT scan
confirmed a mediastinal mass abutting the major vessels. A mag-
netic resonance imaging (MRI) scan demonstrated no signs of
invasion (Figure 1). Intraoperative bronchoscopy was unremark-
able. Exploratory video-assisted thoracic surgery and biopsy re-
vealed that histologic characteristics were consistent with neuro-
fibroma, and a 12  6  3-cm well-circumscribed mass was
readily resected via a posterolateral thoracotomy. The final his-
topathologic analysis confirmed a neurofibroma. She made an
uneventful recovery and remains free of disease 16 months later.
PATIENT 3. A 27-year-old man with prior excision of a right
thigh neurofibroma 10 years earlier presented with a several-month
history of progressive dyspnea and weight loss. A chest radiograph
film showed inhomogeneous opacification of the left hemithorax.
CT scan revealed a large heterogenous mass occupying the entire
left hemithorax with marked mediastinal shift (Figure 2). An MRI
scan demonstrated tumor encasement of the left hilar vessels,
indistinct lung, and the heart displaced into the right hemithorax.
An intraoperative bronchoscopy showed complete extrinsic com-
pression of the upper and lower lobe bronchi. Given the anticipated
technical challenges, resection was approached through a bilateral
transsternal anterolateral thoracotomy (clamshell) incision that al-
lowed for exposure and cardiopulmonary bypass if necessary. The
mass and the completely collapsed and firmly adherent entire left
lung were resected en bloc. The histopathologic characteristics
were pleomorphic sarcoma consistent with a malignant peripheral
nerve sheath tumor. The patient made a satisfactory recovery and
was discharged 10 days later. He died 4 months later of an
inoperable subdiaphragmatic tumor.
Discussion
NF1 is an autosomal dominant neurocutaneous disorder. The NF1
gene mutation is on chromosome 17, and its product, neurofibro-
min, normally functions as a tumor suppressor to reduce cell
proliferation by inactivating the proto-oncogene p21-ras.3 NF1
patients, therefore, have an increased predilection for the develop-
ment of both benign and malignant nerve sheath tumors. Medias-
tinal tumors in NF1 patients are typically neurofibromas that
originate in the posterior mediastinum and have a particular pre-
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Figure 1. An MRI scan of the chest demonstrates a 4.3  7.7-cm
anterosuperior mediastinal mass abutting the aortic arch, its
branches, and the left main pulmonary artery without signs of
invasion.
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disposition for malignant transformation.2 These tumors can re-
main clinically silent and are discovered as incidental findings on
imaging studies or grow to large sizes before causing symptoms or
invasion into adjacent vital structures. CT scan usually provides
sufficient information to assess the mediastinal mass; however, the
radiologic features of benign and malignant peripheral nerve
sheath tumors are nonspecific. MRI scan may further delineate
intraspinal involvement or relationships to critical structures. Cur-
rently, the role for positron emission tomographic imaging remains
undefined. The coexistence of retroperitoneal neurogenic tumors,
although rare, should be recognized during the evaluation and
management of NF1 patients with suspected mediastinal neuro-
genic tumors.
Traditionally, extirpation of mediastinal neurogenic tumors is
approached through a posterolateral thoracotomy. Thoracoscopic
resection of neurogenic tumors continues to mature, with recog-
nized limitations in patients with large (6 cm) tumors, suspected
malignancy, intervertebral extension, and involvement of adjacent
structures.4
Patients with benign tumors and complete resection have ex-
cellent outcomes. Despite delayed referral in our first case and a
location central to vital structures in the second case, both patients
are doing well, having undergone early and complete resection
soon after presentation. The third patient had a poor long-term
outcome despite an aggressive intrathoracic resection and uncom-
plicated postoperative course. Significant prognostic factors in
patients with malignant tumors include size, low histopathologic
grade, and completeness of resection.5 As demonstrated by the 3
cases presented, complete resection is possible in most patients
regardless of the tumor size and location. An aggressive surgical
approach is warranted because of the risk of malignant transfor-
mation and the chemoresistance of these tumors.
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Figure 2. A CT scan of the chest demonstrates a large heteroge-
neous enhancing mass occupying the entire left hemithorax with
mediastinal shift to the right. At resection, the tumor was multi-
lobulated and well circumscribed with a pseudocapsule. It
weighed 13 pounds and measured 40  25  12 cm.
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